Latest Align Technology (ALGN) Headlines Patter
Post# of 47
Posted On: 03/13/2014 5:00:08 AM
Latest Align Technology (ALGN) Headlines
Patterson Companies Down to Sell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 5:15PM CDT
Patterson continues to face a challenging macro environment due to uncertainties surrounding the U.S. healthcare system as well as the ongoing austerity measures that have dampened demand for the past few years.
CR Bard Reaches New 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 8:10AM CDT
Shares of BCR started escalating following optimism triggered by promising 2014 guidance.
Quest Diagnostics Ups View on Solstas Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 11, 4:20PM CDT
With the declaration of the closure of its earlier announced acquisition of Solstas Lab Partners Group and its subsidiaries, Quest Diagnostics also raised its 2014 financial outlook.
DENTSPLY International Raised to Hold - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 11, 2:30PM CDT
Positive earnings guidance and anticipated improvement in the global market conditions in 2014, combined with improving leveraged position and margins, represent a potential upside for DENTSPLY going forward.
Upcoming Conferences, Financial Results, New Products, and Awareness Campaigns - Analyst Notes on Align Technology, LabCorp, Insulet, CareFusion, and DexCom
PR Newswire - Tue Mar 11, 8:20AM CDT
Today, Analysts Review released its analysts' notes regarding Align Technology, Inc. (NASDAQ:ALGN), Laboratory Corp. of America Holdings (NYSE:LH), Insulet Corporation (NASDAQ
ODD), CareFusion Corporation (NYSE:CFN), and DexCom, Inc. (NASDAQ
XCM). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Balanced View Continues for Henry Schein - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 10, 1:50PM CDT
On Mar 07, 2014, we issued an updated research report on Henry Schein Inc.
Most-Recent Breakouts Among IBD 50 Stocks Mixed So Far
at Investor's Business Daily - Fri Mar 07, 5:50PM CST
With most IBD 50 stocks extended from buy points, few choices remain for new purchases, and the most recent breakouts are having mixed results. A few stocks that broke out in the past couple of weeks are above their buy points and acting well enough....
Cooper Companies Beats on Q1 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 07, 1:32PM CST
For fiscal 2014, COO now expects total revenues between $ 1,685 and $1,725 million compared with the prior guidance of $1,675 and $1,735 million.
Align Technology to Present at 26th Annual Roth Conference
Marketwire - Thu Mar 06, 3:54PM CST
Align Technology, Inc. (NASDAQ: ALGN) today announced that Thomas M. Prescott, president and CEO, and David White, CFO of Align Technology, are scheduled to speak at the 26th Annual Roth Conference. The presentation, as noted below, will be webcast live via the Investor Relations section of Align Technology's website at http://investor.aligntech.com. An archived replay will remain on the web site for approximately three months.
Bio-Reference Laboratories (BRLI) Falls: Stock Goes Down 5.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 06, 7:42AM CST
Bio-Reference Laboratories saw a big move last session on pretty good volume with far more shares changing hands than in a normal session; shares fell over 5% on the day.
Weakness Seen in STAAR Surgical (STAA) Estimates: Should You Stay Away? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 05, 7:46AM CST
STAAR Surgical has seen negative earnings estimate revisions for the current quarter along with a significant decline in its share price for the past month.
OrthoAccel® Technologies Inc. Announces Addition of Leading Orthodontist, Dr. Sam Daher, to Key Opinion Leadership Group
PR Newswire - Wed Mar 05, 7:00AM CST
OrthoAccel® Technologies, Inc. (OrthoAccel) announced today the addition of distinguished Canadian orthodontist, Dr. Sam Daher, to its Key Opinion Leadership Group of world-class clinicians who present scientific and clinical evidence supporting OrthoAccel's groundbreaking medical device, AcceleDent®, to orthodontists interested in incorporating the treatment modality into their practice. Now available in over 1,000 orthodontic locations in North America, AcceleDent is the only FDA-cleared, Class II medical device that speeds up orthodontic treatment by as much as 50 percent.
Align Technology Announces Retirement of David E. Collins From Board of Directors
Marketwire - Tue Mar 04, 3:00PM CST
Align Technology, Inc. (NASDAQ: ALGN) today announced that David E. Collins intends to retire from the Company's board of directors, effective immediately prior to the 2014 Annual Meeting of Stockholders scheduled for May 15, 2014. In connection with his retirement, Mr. Collins will not stand for reelection at the Annual Meeting. Mr. Collins has served on the Align Technology board since 2003, and is a member of the audit and compensation committees. The Company does not intend to fill Mr. Collin's board seat.
Insider Trading Alert - ALGN, JNPR And WWAV Traded By Insiders
at The Street - Tue Mar 04, 11:16AM CST
Stocks with insider trader activity include ALGN, JNPR and WWAV
Henry Schein, P&G Sign Distribution Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 28, 3:00PM CST
Recently, Henry Schein inked a distribution deal with The Procter & Gamble Company.
Patterson Companies Q3 Meets Expectations - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 20, 10:05AM CST
Revenues for the quarter grew 18.2% to $1,082.7 million, higher than the Zacks Consensus Estimate of $1,062 million.
Align Technology Announces Digital Implant Restorative Workflow With DENTSPLY Implants Atlantis Custom Abutments
Marketwire - Thu Feb 20, 7:02AM CST
Align Technology, Inc. (NASDAQ: ALGN) today announced an agreement with DENTSPLY Implants in which the iTero(R) Intraoral Scanner will soon feature connectivity with ATLANTIS(TM) custom abutments. In uniting technology from two market leaders, the digital workflow will offer dental professionals, periodontists and oral surgeons a digital implant restorative procedure that will provide greater precision and enhanced efficiency.
McKesson Expands Agreement with Rite Aid - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 19, 5:10PM CST
McKesson Corporation recently announced that it has expanded its distribution agreement with Rite Aid Corporation (RAD).
DENTSPLY International Q4 Earnings Beat by a Penny - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 19, 3:05AM CST
For full year 2013, adjusted net earnings per share rose 5.9% to $2.35 from $2.22 a year ago and were in line with the Zacks Consensus Estimate.
Patterson Companies Down to Sell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 5:15PM CDT
Patterson continues to face a challenging macro environment due to uncertainties surrounding the U.S. healthcare system as well as the ongoing austerity measures that have dampened demand for the past few years.
CR Bard Reaches New 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 8:10AM CDT
Shares of BCR started escalating following optimism triggered by promising 2014 guidance.
Quest Diagnostics Ups View on Solstas Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 11, 4:20PM CDT
With the declaration of the closure of its earlier announced acquisition of Solstas Lab Partners Group and its subsidiaries, Quest Diagnostics also raised its 2014 financial outlook.
DENTSPLY International Raised to Hold - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 11, 2:30PM CDT
Positive earnings guidance and anticipated improvement in the global market conditions in 2014, combined with improving leveraged position and margins, represent a potential upside for DENTSPLY going forward.
Upcoming Conferences, Financial Results, New Products, and Awareness Campaigns - Analyst Notes on Align Technology, LabCorp, Insulet, CareFusion, and DexCom
PR Newswire - Tue Mar 11, 8:20AM CDT
Today, Analysts Review released its analysts' notes regarding Align Technology, Inc. (NASDAQ:ALGN), Laboratory Corp. of America Holdings (NYSE:LH), Insulet Corporation (NASDAQ
ODD), CareFusion Corporation (NYSE:CFN), and DexCom, Inc. (NASDAQ XCM). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register Balanced View Continues for Henry Schein - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 10, 1:50PM CDT
On Mar 07, 2014, we issued an updated research report on Henry Schein Inc.
Most-Recent Breakouts Among IBD 50 Stocks Mixed So Far
at Investor's Business Daily - Fri Mar 07, 5:50PM CST
With most IBD 50 stocks extended from buy points, few choices remain for new purchases, and the most recent breakouts are having mixed results. A few stocks that broke out in the past couple of weeks are above their buy points and acting well enough....
Cooper Companies Beats on Q1 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 07, 1:32PM CST
For fiscal 2014, COO now expects total revenues between $ 1,685 and $1,725 million compared with the prior guidance of $1,675 and $1,735 million.
Align Technology to Present at 26th Annual Roth Conference
Marketwire - Thu Mar 06, 3:54PM CST
Align Technology, Inc. (NASDAQ: ALGN) today announced that Thomas M. Prescott, president and CEO, and David White, CFO of Align Technology, are scheduled to speak at the 26th Annual Roth Conference. The presentation, as noted below, will be webcast live via the Investor Relations section of Align Technology's website at http://investor.aligntech.com. An archived replay will remain on the web site for approximately three months.
Bio-Reference Laboratories (BRLI) Falls: Stock Goes Down 5.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 06, 7:42AM CST
Bio-Reference Laboratories saw a big move last session on pretty good volume with far more shares changing hands than in a normal session; shares fell over 5% on the day.
Weakness Seen in STAAR Surgical (STAA) Estimates: Should You Stay Away? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 05, 7:46AM CST
STAAR Surgical has seen negative earnings estimate revisions for the current quarter along with a significant decline in its share price for the past month.
OrthoAccel® Technologies Inc. Announces Addition of Leading Orthodontist, Dr. Sam Daher, to Key Opinion Leadership Group
PR Newswire - Wed Mar 05, 7:00AM CST
OrthoAccel® Technologies, Inc. (OrthoAccel) announced today the addition of distinguished Canadian orthodontist, Dr. Sam Daher, to its Key Opinion Leadership Group of world-class clinicians who present scientific and clinical evidence supporting OrthoAccel's groundbreaking medical device, AcceleDent®, to orthodontists interested in incorporating the treatment modality into their practice. Now available in over 1,000 orthodontic locations in North America, AcceleDent is the only FDA-cleared, Class II medical device that speeds up orthodontic treatment by as much as 50 percent.
Align Technology Announces Retirement of David E. Collins From Board of Directors
Marketwire - Tue Mar 04, 3:00PM CST
Align Technology, Inc. (NASDAQ: ALGN) today announced that David E. Collins intends to retire from the Company's board of directors, effective immediately prior to the 2014 Annual Meeting of Stockholders scheduled for May 15, 2014. In connection with his retirement, Mr. Collins will not stand for reelection at the Annual Meeting. Mr. Collins has served on the Align Technology board since 2003, and is a member of the audit and compensation committees. The Company does not intend to fill Mr. Collin's board seat.
Insider Trading Alert - ALGN, JNPR And WWAV Traded By Insiders
at The Street - Tue Mar 04, 11:16AM CST
Stocks with insider trader activity include ALGN, JNPR and WWAV
Henry Schein, P&G Sign Distribution Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 28, 3:00PM CST
Recently, Henry Schein inked a distribution deal with The Procter & Gamble Company.
Patterson Companies Q3 Meets Expectations - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 20, 10:05AM CST
Revenues for the quarter grew 18.2% to $1,082.7 million, higher than the Zacks Consensus Estimate of $1,062 million.
Align Technology Announces Digital Implant Restorative Workflow With DENTSPLY Implants Atlantis Custom Abutments
Marketwire - Thu Feb 20, 7:02AM CST
Align Technology, Inc. (NASDAQ: ALGN) today announced an agreement with DENTSPLY Implants in which the iTero(R) Intraoral Scanner will soon feature connectivity with ATLANTIS(TM) custom abutments. In uniting technology from two market leaders, the digital workflow will offer dental professionals, periodontists and oral surgeons a digital implant restorative procedure that will provide greater precision and enhanced efficiency.
McKesson Expands Agreement with Rite Aid - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 19, 5:10PM CST
McKesson Corporation recently announced that it has expanded its distribution agreement with Rite Aid Corporation (RAD).
DENTSPLY International Q4 Earnings Beat by a Penny - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 19, 3:05AM CST
For full year 2013, adjusted net earnings per share rose 5.9% to $2.35 from $2.22 a year ago and were in line with the Zacks Consensus Estimate.
(0)
(0)Align Technology Inc. (ALGN) Stock Research Links
Scroll down for more posts ▼